Opioid Use Disorder
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding telemedicine prescribing of buprenorphine will be delayed from Feb. 18 to March 21.
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Jan. 15 released a proposed rule on special registration for prescribing of controlled substances and a final rule on telemedicine prescribing of buprenorphine.
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what Englewood Health is doing to prevent opioid use in its communities.
Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to meet the behavioral health needs of its communities.
For underserved populations, stigma and lack of access to behavioral health services can present huge barriers to treatment. In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to meet the…
The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention as part of its National Partners Cooperative Agreement. The funding will support hospitals and health systems in their efforts to address opioid and stimulant use disorder…
The American Hospital Association (AHA) today announced it has been awarded nearly $1.5 million in funding from the Centers for Disease Control and Prevention (CDC) as part of its National Partners Cooperative Agreement. This funding will support hospitals and health systems in their efforts to…
In this conversation, Chris DeRienzo, M.D., SVP and chief physician executive at the AHA, speaks with three WISH Center experts about how its approach is helping to protect the health of new mothers and their babies.
The AHA Dec. 7 sent a letter supporting the Support for Patients and Communities Reauthorization Act (H.R. 4531), bipartisan legislation that would reauthorize key SUPPORT Act programs for patients with substance use disorder and permanently extend required Medicaid coverage for medication-assisted…
The Centers for Disease Control and Prevention recently awarded $279 million to help state and local health departments respond to the drug overdose crisis through treatment and surveillance.